ACCP Recent News Access Pharmaceuticals Announces
Post# of 58
Access Pharmaceuticals Announces Publication Of MuGard Clinical Data In Cancer Journal PR Newswire - Tue Feb 18, 7:30AM CST
Market Research: Male Infertility - Pipeline Review, H2 2013 M2 - Wed Dec 11, 2:44AM CST
Global Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2013 M2 - Wed Nov 20, 3:34AM CST
Ovarian Cancer - Pipeline Review, H2 2013 Reviews Key Players Involved in the Therapeutic Development for Ovarian Cancer M2 - Wed Nov 06, 4:05AM CST
OTC Signal Daily Stock Watch - Access Pharmaceuticals, Inc. (OTCQB: ACCP) WorldStockWire - Mon Oct 14, 12:00AM CDT
Access Pharmaceuticals Awarded Second European Patent for MuGard PR Newswire Europe - Thu Sep 12, 7:31AM CDT
Women Infertility - Pipeline Review, H2 2013 Report Features Players such as Merck KGaA, EndoCeutics, Inc. and Quatrx Pharmaceutical Company M2 - Thu Aug 08, 12:19PM CDT
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2012 M2 - Wed Jul 31, 6:40AM CDT
Access Pharmaceuticals To Host Investor Call On Wednesday, July 31, 2013 PR Newswire - Fri Jul 26, 10:00AM CDT